Verzenio Patent Protection
1 patents · Eli Lilly and Company
Patent Details
| Patent # | Title | Assignee | Expires | Status |
|---|---|---|---|---|
| 7855211 | Drug substance & product patent | Eli Lilly and Company | Sep 28, 2031 | 5.3y left |
Related Drug Patent Expirations
8 patents · earliest expires 2036 · Eli Lilly and Company
0 patents · Eli Lilly and Company
0 patents · Eli Lilly and Company
45 patents · earliest expires 2031 · AbbVie Inc.
3 patents · earliest expires 2030 · Celgene Corporation
5 patents · earliest expires 2032 · AstraZeneca AB
For Verzenio, the underlying data on this page comes from the FDA Orange Book and USPTO patent records. The breakdown above is the federal record; the paragraphs below add the per-entity context that makes the headline numbers usable for a real decision rather than just a data lookup.
Every number on this page links back to the FDA Orange Book and USPTO patent records; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.
For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for Verzenio is typically a peer within U.S. brand-name drugs with similar size, similar exposure, or similar geography — not the national-level summary alone.